Do you want to read an article? Please log in or register.
Elevated on-treatment D-dimer level is associated with major bleeding during extended anticoagulation for venous thromboembolism
Non-Malignant Blood Disorders
Related content
Further Publications
Predictors of clinically relevant bleeding during extended anticoagulation for cancer-associated venous thromboembolism (API-CAT): a post-hoc analysis of a randomised, non-inferiority trial
Lancet Haematol
Mahé I, Chapelle C, Girard P, Carrier M, Palomares LJ, Samama CM, Helfer H, Gerotziafas G, Laporte S, Vicaut E, Mismetti P, API-CAT Study Group, API-CAT Investigators
doi: 10.1016/S2352-3026(25)00291-1
RECOMMENDED
Further Publications
Reduced-Dose Versus Full-Dose Direct Oral Anticoagulants for Extended Secondary Venous Thromboembolism Prophylaxis in Cancer Patients: A Systematic Review and Meta-Analysis of Randomized Trials
★ 2
Recommended by
Dr Andreas Müller, Faculty Member
Am J Hematol
Mahmoud A, Eltaher B, Shah P, Vengilote R, Mostafa M, Afzal A, Sanfilippo KM
doi: 10.1002/ajh.70090
Non-Malignant Blood Disorders
Apixaban for the treatment of venous thromboembolic events in paediatric patients: an open-label, multicentre, randomised, controlled descriptive trial
Lancet Haematol
Brandão LR, Driscoll J, Newburger JW, Holzhauer S, Ahuja S, Rubio AE, Gaitonde P, Robertson A, Polinsky M, Revkin JH, Masiukiewicz U, O'Brien SH, Mitchell LG, Pediatric Apixaban VTE Study Investigators
doi: 10.1016/S2352-3026(26)00107-9
Non-Malignant Blood Disorders
Molecular Determinants of Thrombosis Recurrence Risk Across Venous Thromboembolism Subtypes
Blood
Munsch G, Thibord F, Bezerra OC, Brody JA, van Hylckama Vlieg A, Gourhant L, Chen MH, Samaria F, Germain M, Caro I, Suchon P, Olaso R, Wiggins KL, Saut N, Besse C, Goumidi L, Bacq D, Harrington LB, Boland A, Emmerich J, Smadja DM, Lemarie CA, Danckwardt S, Debette S, Deleuze JF, Jacqmin-Gadda H, Rodger MA, Gagnon F, Rosendaal FR, Johnson AD, Smith NL, Couturaud F, Morange PE, Tregouet DA
doi: 10.1182/blood.2024027879
Non-Malignant Blood Disorders
The Impact of Anticoagulation in Patients With Isolated Cancer-Associated Splanchnic Vein Thrombosis: A Dual-Center Cohort Study
Am J Hematol
Borad A, Andersen M Jr, Guffey D, Shang H, Jiang JY, Fernandez Turizo MJ, Berry J, Zwicker JI, Patell R, Li A
doi: 10.1002/ajh.70287
Head and Neck Cancer
De-escalated adjuvant radiotherapy versus standard adjuvant treatment for human papillomavirus-associated oropharyngeal squamous cell carcinoma (MC1675): a phase 3, open-label, randomised controlled trial
Lancet Oncol
Ma D, Price K, Moore E, Patel S, Hinni M, Routman D, Fruth B, Foster N, Van Abel K, Yin L, Neben-Wittich M, Garces Y, McGee L, Lester S, Rwigema JC, Holtzman A, Price D, Janus J, Kasperbauer J, Chintakuntlawar A, Garcia J, Foote R
doi: 10.1016/S1470-2045(25)00324-9
Non-Malignant Blood Disorders
Circulating erythropoietin concentration associates with thromboembolism in sickle cell disease
Br J Haematol
Zhang X, Shah BN, Han J, Nouraie M, Zhang Y, Machado RF, Gladwin MT, Saraf SL, Gordeuk VR
doi: 10.1111/bjh.70517
Further Publications
Cancer-associated arterial thromboembolism: real-world burden from a nationwide electronic health record database
J Natl Cancer Inst
Koh HY, Sukumar S, Yang Z, Preeti P, Jiang JY, Kim RB, Ranjan M, Guffey D, Jafari O, Li A
doi: 10.1093/jnci/djag204
Non-Malignant Blood Disorders
Incidence and predictors of recurrent venous thromboembolism after isolated distal deep vein thrombosis: a post-hoc analysis of the RIDTS trial
Haematologica
Potere N, Bertù L, Bucherini E, Camporese G, Dentali F, Iotti M, Lessiani G, Parisi R, Prandoni P, Sartori M, Zalunardo B, Palareti G, Ageno W
doi: 10.3324/haematol.2026.300664